argenx SE American Depositary Shares (ARGX) News
Latest headlines that mention ARGX, newest first · each headline opens the original publisher
- Last price
- $818.30
- Day change
- +1.95%
- Next earnings
- 2026-10-22 BMO
ARGX headlines
last 30 daysArgenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response. The post Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's appeared first on Investor's Business Daily .
Find insight on Roche Holding, GSK, Argenx and more in the latest Market Talks covering the health care sector.
This biotech stock could soar 30% or more over the next 12 months if some analysts are right.
There are good reasons behind analyst's bullish views of this biotech stock.
It's easy to be bullish about Argenx.
ARGX news alerts
Get an alert by email or push when a new headline mentions ARGX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.